Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Diagnostic Equipment

Ortho-Clinical Diagnostics, Inc.: VITROS Chemistry FS Diluent Pack 3 Recalled for Potential Biased Test Results

Agency Publication Date: July 3, 2024
Share:
Sign in to monitor this recall

Summary

Ortho-Clinical Diagnostics, Inc. has recalled approximately 1,000 units of VITROS Chemistry Products FS Diluent Pack 3, specifically Lot 01-1645. This laboratory diluent is used during blood testing to prepare patient samples for C-Reactive Protein (CRP) analysis. The product was recalled because it may cause test results to be negatively biased, meaning the results could appear lower than they actually are, potentially leading to incorrect medical interpretations. Consumers who have had CRP testing performed with this specific diluent lot may need to have their results reviewed by a physician.

Risk

The affected diluent can cause inaccurately low C-Reactive Protein (CRP) test results. This bias could lead healthcare providers to underestimate the level of inflammation or infection in a patient, potentially delaying necessary medical treatment or resulting in a misdiagnosis.

What You Should Do

  1. Identify if your lab or healthcare facility is using VITROS Chemistry Products FS Diluent Pack 3 with Lot Number 01-1645 and Expiration Date 05-Jul-2024.
  2. Check the product packaging for Model/Catalog Number 6801754 and UDI-DI 10758750007004 to confirm the affected unit.
  3. Immediately stop using any remaining inventory from Lot 01-1645 and quarantine the product to prevent further testing errors.
  4. If you are a patient who recently received CRP test results, contact your healthcare provider to determine if your sample was processed using this specific lot and if re-testing is required.
  5. Healthcare facilities should follow the instructions provided in the manufacturer's notification letter regarding the disposal or return of the affected packs.
  6. Contact Ortho-Clinical Diagnostics, Inc. at their Rochester, NY headquarters or through your local representative for further technical instructions and to report any issues.
  7. For additional questions, contact the FDA at 1-888-463-6332 (1-888-INFO-FDA) or visit www.fda.gov/medical-devices/medical-device-recalls.

Your Remedy Options

๐Ÿ“‹Other Action

Technical review and manufacturer consultation

How to: Contact your healthcare provider or the manufacturer for further instructions and potential refund

Affected Products

Product: VITROS Chemistry Products FS Diluent Pack 3 (3 packs per sales unit)
Model / REF:
6801754
UPC Codes:
10758750007004
Lot Numbers:
01-1645
Date Ranges: Expiration Date: 05-Jul-2024

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 94770
Status: Active
Manufacturer: Ortho-Clinical Diagnostics, Inc.
Sold By: Laboratory suppliers; Direct medical distribution
Manufactured In: United States
Units Affected: 1000
Distributed To: Florida, Illinois, New York, Pennsylvania

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.